AorTech International Share Price, News & Analysis (LON:AOR) Add Compare Share Share Today's Range N/A50-Day Range 123.50▼ 123.5052-Week Range N/AVolume7,419 shsAverage Volume40,686 shsMarket Capitalization£19.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A About AorTech InternationalAorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.Read More AOR Stock News HeadlinesApril 24, 2023 | marketwatch.com2023-2030 Bioprosthetics Market Size with [95 Pages] includes Industry Chain Analysis | New Report by Absolute ReportsMarch 30, 2023 | marketwatch.comElectrophysiology (EP) Ablation Catheters Market by 2031December 6, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMarch 20, 2023 | marketwatch.comBioprosthetics Market Major Players, Anlysis and Forecast till 2028March 4, 2023 | marketwatch.comGlobal Bioprosthetics Market 2023 Growth Opportunities, Top Players, Regions, Application, and Forecast to 2030 By VMReportsFebruary 16, 2023 | marketwatch.comMechanical Heart Valve Market Outlook 2023 and Forecast to 2028 with Top Countries DataJanuary 18, 2023 | marketwatch.comMechanical Heart Valve Market 2023 : Manufacturers Strategies, Share Estimation, Future Demand and Regional Growth Dynamics 2029September 21, 2022 | marketwatch.comPercutaneous Mitral Valve Repair Device Market 2022-2028 Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & AnalysisDecember 6, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comJune 10, 2022 | marketwatch.comCardiac Valve Market-Industry Analysis, Share, Size Trends, Demand, Growth, Revenue, Top Companies and Forecasts 2022 to 2028December 16, 2021 | lse.co.ukTRADING UPDATES: Listing costs hobble Orcadian and ProCook earningsOctober 20, 2021 | ca.finance.yahoo.comGlobal Bioprosthetics Market Research Report (2021 to 2026) - by Type, Application and Region - ResearchAndMarkets.comSeptember 2, 2021 | proactiveinvestors.comRUA Life Sciences - Result of AGMAugust 31, 2021 | proactiveinvestors.comRUA Life Sciences - AGM Statement and Trading UpdateAugust 10, 2021 | proactiveinvestors.comRUA Life Sciences - Directorate ChangeMarch 26, 2021 | au.finance.yahoo.comRUA LIFE SCIENCES LS0,05 (AOHA.BE)January 19, 2021 | thetimes.co.ukRua Life Sciences changes chemistry in boardroomJanuary 13, 2021 | marketwatch.comGlobal Percutaneous Mitral Valve Repair Device Market 2020 Regional Demand, Industry Top Players Study, Key Trends and SWOT Analysis to 2025January 8, 2021 | marketwatch.comBioprosthetics Market Share Analysis, Key Growth Drivers, Challenges, Leading Key Players Review, Demand and Upcoming Trend by Forecast to 2026November 5, 2020 | thetimes.co.ukMacdonald HendersonNovember 4, 2020 | marketwatch.comUS Heart Valve Repair and Replacement Market: Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025October 20, 2020 | finance.yahoo.comRua Life Sciences Plc's (LON:RUA) Shift From Loss To ProfitSeptember 18, 2020 | marketwatch.comAt 10.30% CAGR, Heart Valve Repair And Replacement Market Size | Share, Trends, Growth | Research Development Report To 2025September 6, 2020 | marketwatch.comGlobal Percutaneous Mitral Valve Repair Device Market 2020 Key Drivers and Restraints, Regional Outlook, End-User Applicants by 2025September 2, 2020 | marketwatch.comGlobal Percutaneous Mitral Valve Repair Device Market 2020 by Future Developments, Upcoming Trends, Growth Drivers and Challenges 2020 to 2025August 12, 2020 | lse.co.ukRua Life Sci. Regulatory NewsAugust 7, 2020 | marketwatch.comUS Heart Valve Repair And Replacement Market share, Growth, Forecast By Applications, Dynamics, Development Status And Outlook 2025See More Headlines Receive AOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AorTech International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:AOR CUSIPN/A CIKN/A Webwww.aortech.net Phone+44-1932-252123FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio32.06 Quick Ratio32.06 Sales & Book Value Annual Sales£539,000.00 Price / Sales37.09 Cash FlowGBX 14.82 per share Price / Cash Flow8.33 Book ValueGBX 19.40 per share Price / Book6.37Miscellaneous Outstanding Shares16,186,600Free FloatN/AMarket Cap£19.99 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. William Donald Brown (Age 55)CEO, Exec. Chairman & Fin. Director Mr. John McKenna (Age 66)Director of Clinical Marketing & Exec. Director Mr. Ajay Padsalgikar Ph.D.Chief Scientific OfficerMr. David J. C. ParsonsCompany Sec.Key CompetitorsOncimmuneLON:ONCOndine BiomedicalLON:OBISynairgenLON:SNGOKYO PharmaLON:OKYOOptiBiotix HealthLON:OPTIView All Competitors AOR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of AorTech International own? Based on aggregate information from My MarketBeat watchlists, some companies that other AorTech International investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Ascential (ASCL), Empyrean Energy (EME), Lloyds Banking Group (LYG), Starbucks (SBUX), Activision Blizzard (ATVI), Alphabet (GOOG), Petropavlovsk (POG) and Scancell (SCLP). How do I buy shares of AorTech International? Shares of AOR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AOR) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AorTech International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.